465 related articles for article (PubMed ID: 27429034)
1. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction.
Anderegg MC; Lagarde SM; Jagadesham VP; Gisbertz SS; Immanuel A; Meijer SL; Hulshof MC; Bergman JJ; van Laarhoven HW; Griffin SM; van Berge Henegouwen MI
Ann Surg; 2016 Nov; 264(5):847-853. PubMed ID: 27429034
[TBL] [Abstract][Full Text] [Related]
2. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
[TBL] [Abstract][Full Text] [Related]
3. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.
Lerut T; Nafteux P; Moons J; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Ectors N
Ann Surg; 2004 Dec; 240(6):962-72; discussion 972-4. PubMed ID: 15570202
[TBL] [Abstract][Full Text] [Related]
4. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
[TBL] [Abstract][Full Text] [Related]
5. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic.
Schomas DA; Quevedo JF; Donahue JM; Nichols FC; Romero Y; Miller RC
Dis Esophagus; 2010 Apr; 23(3):232-9. PubMed ID: 19515184
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
Lagarde SM; Phillips AW; Navidi M; Disep B; Griffin SM
Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881884
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
8. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction.
van de Ven C; De Leyn P; Coosemans W; Van Raemdonck D; Lerut T
Eur J Cardiothorac Surg; 1999 Jun; 15(6):769-73. PubMed ID: 10431857
[TBL] [Abstract][Full Text] [Related]
9. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study.
Hagens ERC; van Berge Henegouwen MI; van Sandick JW; Cuesta MA; van der Peet DL; Heisterkamp J; Nieuwenhuijzen GAP; Rosman C; Scheepers JJG; Sosef MN; van Hillegersberg R; Lagarde SM; Nilsson M; Räsänen J; Nafteux P; Pattyn P; Hölscher AH; Schröder W; Schneider PM; Mariette C; Castoro C; Bonavina L; Rosati R; de Manzoni G; Mattioli S; Garcia JR; Pera M; Griffin M; Wilkerson P; Chaudry MA; Sgromo B; Tucker O; Cheong E; Moorthy K; Walsh TN; Reynolds J; Tachimori Y; Inoue H; Matsubara H; Kosugi SI; Chen H; Law SYK; Pramesh CS; Puntambekar SP; Murthy S; Linden P; Hofstetter WL; Kuppusamy MK; Shen KR; Darling GE; Sabino FD; Grimminger PP; Meijer SL; Bergman JJGHM; Hulshof MCCM; van Laarhoven HWM; Mearadji B; Bennink RJ; Annema JT; Dijkgraaf MGW; Gisbertz SS
BMC Cancer; 2019 Jul; 19(1):662. PubMed ID: 31272485
[TBL] [Abstract][Full Text] [Related]
10. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
11. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
12. Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarcinoma of the distal esophagus or gastric cardia.
Buskens CJ; Ten Kate FJ; Obertop H; Izbicki JR; van Lanschot JJ
Dis Esophagus; 2008; 21(6):488-95. PubMed ID: 18840133
[TBL] [Abstract][Full Text] [Related]
13. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
[TBL] [Abstract][Full Text] [Related]
14. Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction.
Mönig SP; Baldus SE; Zirbes TK; Collet PH; Schröder W; Schneider PM; Dienes HP; Hölscher AH
Hepatogastroenterology; 2002; 49(44):419-22. PubMed ID: 11995464
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastases near the celiac trunk should be considered separately from other nodal metastases in patients with cancer of the esophagus or gastroesophageal junction after neoadjuvant treatment and surgery.
Lagarde SM; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Laarhoven HWM; van Berge Henegouwen MI
J Thorac Dis; 2018 Mar; 10(3):1511-1521. PubMed ID: 29707301
[TBL] [Abstract][Full Text] [Related]
16. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy.
Nigro JJ; DeMeester SR; Hagen JA; DeMeester TR; Peters JH; Kiyabu M; Campos GM; Oberg S; Gastal O; Crookes PF; Bremner CG
J Thorac Cardiovasc Surg; 1999 May; 117(5):960-8. PubMed ID: 10220691
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
18. The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomas.
Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Yamagishi H
Jpn J Clin Oncol; 2006 Dec; 36(12):775-82. PubMed ID: 17043058
[TBL] [Abstract][Full Text] [Related]
19. Treatment of clinical T2N0M0 esophageal cancer.
Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
